Pharmaceutical

Cipla and Glenmark initiate recall of certain products in the US

Cipla and Glenmark Pharmaceuticals are recalling specific products from the US market due to distinct manufacturing issues.

May 7, 2024 - 00:00
Cipla and Glenmark initiate recall of certain products in the US
Cipla and Glenmark Pharmaceuticals are recalling specific products from the US market due to distinct manufacturing issues.
Read the original article

Tags:

Previous Article

Fighting cancer with artificial cells

Next Article

Lantern Pharma and Oregon partner to develop cancer treatment

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: A Q&A with the CEO of CRISPR Therapeutics on a historic approval and the road ahead

STAT+: A Q&A with the CEO of CRISPR Therapeutics on a h...

Dec 9, 2023

STAT+: Researchers create talking throat patch for people with voice disorders

STAT+: Researchers create talking throat patch for peop...

Mar 13, 2024

Eculizumab biosimilar by Turgut Ilaclari for Neuromyeli...

Jul 1, 2023